Characterising CD8+ T cell transcriptomic and clonal consequences of immune checkpoint blockade for the treatment of cancer
<p><b>Background:</b> Immune checkpoint blockade (ICB) is arguably the greatest advance in medical oncology this century. Nonetheless, responses are highly variable. Mechanistic insights into this heterogeneity promises to improve patient stratification and identification of thera...
Auteur principal: | Watson, RA |
---|---|
Autres auteurs: | Fairfax, B |
Format: | Thèse |
Langue: | English |
Publié: |
2023
|
Sujets: |
Documents similaires
-
Immune Checkpoint Blockade sensitivity and Progression-Free Survival associates with baseline CD8+ T cell clone size and cytotoxicity
par: Watson, R, et autres
Publié: (2021) -
Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade
par: Sharmila Nair, et autres
Publié: (2021-01-01) -
Dissecting peripheral CD8+ T cell responses and immune interactions during immune checkpoint blockade for metastatic melanoma
par: Tong, O
Publié: (2023) -
Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma
par: Cristina Valero, et autres
Publié: (2023-10-01) -
Mathematical modelling and transcriptional characterisation of intratumoral regulatory T cell sub-populations
par: Muzhingi, I
Publié: (2023)